扬子晚报网2月22日讯（记者 姜婧仪 通讯员 江轩）一年春作首，万事行为先。今年春节假期，在南京 江宁区"暖心六条"政策的激励下，江宁区139家规上企业连续生产，铆足干劲赶订单、抢进度，以全新 姿态和饱满热情开启新年"加速跑"，助力区域经济发展实现首季"开门红"。 春节期间，位于滨江开发区的中材锂膜（南京）有限公司的生产车间内一派火热忙碌景象，8条智能自 动化产线满负荷运转，300余名员工错峰值守、轮班作业，确保高效稳定生产。 生产线"马力全开" 该公司专业从事高性能锂电池隔膜的研发、生产、销售及技术服务，产品广泛应用于新能源汽车动力电 池、储能电池、3C消费电池等领域。由于近期市场需求持续旺盛，订单量同比大幅增长，为确保订单 按时交付、满足市场供应，春节假期企业统筹安排生产运营，抢抓生产、全力赶工，全力保障生产经营 运行。 在位于江宁街道的林德梅山（南京）气体有限公司厂区内，生产装置连续稳定运行，各类工业气体、医 用氧等关键产品有序生产、稳定保供。 转自：扬子晚报 春节期间，为保障产品供应，南京卫岗乳业有限公司的一线员工们仍坚守在生产线上，为千家万户送去 新鲜、美味的牛奶。 车间内，工人们从头到脚"全副武装 ...

Core Insights - Ultra-pure gases (purity ≥ 99.999%, or 5N and above) are essential materials for high-tech industries such as semiconductors, photovoltaics, aerospace, and quantum computing. The demand for gas purity has led to advancements in gas purification technology from basic physical separation to intelligent and integrated processes [1][6][9]. Industry Overview - The gas purification industry encompasses three main segments: raw material supply, purification processing, and end-use applications. The upstream focuses on gas raw material collection, including air separation, industrial by-product gases, natural gas purification, and specialty gas synthesis. The midstream emphasizes purification technologies such as adsorption, membrane separation, low-temperature distillation, and chemical absorption to enhance gas purity. The downstream applications are diverse, with high-purity nitrogen and argon required for semiconductor manufacturing, medical oxygen and anesthetic gases in healthcare, high-purity hydrogen in the chemical industry, nitrogen for food packaging, and high-purity hydrogen in the renewable energy sector [1][9][10]. Market Size and Growth - The global ultra-pure gas market is projected to reach approximately $36 billion by 2024, with a compound annual growth rate (CAGR) of about 6.5% from 2020 to 2024 [11][12]. Competitive Landscape - The high-end market for ultra-pure gas purification equipment in China has long been dominated by international giants such as Entegris, Air Water Mechatronics Inc., and Taiyo Nippon Sanso. These companies leverage their deep technical expertise, high-performance products, and broad applicability to maintain a competitive edge. Domestic companies are rapidly catching up in purification technology, product quality, and service [2][13]. Research Methodology - The research team at Huajing Industry Research Institute employs a combination of desktop research, quantitative surveys, and qualitative analysis to comprehensively assess the gas purification industry's market capacity, industry chain, operational characteristics, profitability, and business models. Various analytical models such as SCP, SWOT, PEST, regression analysis, and SPACE matrix are utilized to analyze the market environment, industry policies, competitive landscape, technological innovations, market risks, industry barriers, opportunities, and challenges [2][20]. Future Outlook - The report titled "2026-2032 China Gas Purification Industry Development Dynamic Monitoring and Investment Opportunity Insight Report" provides a detailed analysis of the gas purification industry's development environment and market operations, focusing on competitive dynamics and key enterprises' operational status. It aims to serve as a crucial tool for enterprises, research institutions, and investment organizations to understand the latest industry developments and make informed decisions [20][38].

Core Points - The announcement details the results of GMP compliance inspections conducted on 12 pharmaceutical manufacturing companies in Yunnan Province from May to August 2025 [2]. Group 1: Inspection Results - All inspected companies received a "compliant" rating, indicating they met the required standards for Good Manufacturing Practice (GMP) [2]. - The inspections covered various products, including large-volume injections, traditional Chinese medicine pieces, and small-volume injections [2]. - Specific companies inspected include: - Kunming Nanjing Pharmaceutical Co., Ltd. for large-volume injections [2]. - Kunming Pharmaceutical Group Co., Ltd. for lyophilized powder injections [2]. - Yunnan Youjin Traditional Chinese Medicine Technology Co., Ltd. for traditional Chinese medicine pieces [2]. - China Medical Science Institute for Sabin strain inactivated polio vaccine production [2]. Group 2: Inspection Timeline - Inspections were conducted between June 17 and August 7, 2025, with results announced in July and August 2025 [2]. - The inspection periods varied by company, with some inspections lasting several days [2].

Core Viewpoint - The company, Qiaoyuan Co., focuses on the production of high-purity gases such as oxygen, nitrogen, argon, medical oxygen, food-grade nitrogen, and industrial oxygen, serving various industries including metallurgy, chemicals, healthcare, food, new energy, semiconductors, electronics, biomedicine, and new materials [1] Group 1 - The company is continuously optimizing its production processes to enhance gas purity and production efficiency, catering to diverse customer needs [1] - The company holds necessary licenses for the production and operation of hazardous chemicals, pharmaceutical production, gas cylinder filling, and road transportation of hazardous goods, ensuring compliance with regulatory standards [1] - A comprehensive quality management system and safety production standards have been established to guarantee stable and reliable product quality [1] Group 2 - The company is currently advancing a project focused on the recovery of low-temperature nitrogen gas from atmospheric liquid nitrogen storage tanks, aiming to achieve energy savings and efficient resource utilization through process improvements [1]

Core Insights - The Guizhou Provincial Drug Administration conducted a second round of supervision and inspection on drug production companies in Guizhou Province, with results now published [2][3] Summary by Category Inspection Results - A total of 20 companies were inspected, with 18 companies meeting the compliance requirements, while 2 companies were found non-compliant [3] - The non-compliant companies include: - Guizhou Tiandi Pharmaceutical Co., Ltd., which had its production and sales of glucose injection (20ml:10g) suspended and was referred to law enforcement for further investigation [3] - Guizhou Qiandongnan Miao and Dong Autonomous Prefecture Acetylene Oxygen Plant, which had its production and sales of medical oxygen suspended and was also referred to law enforcement for further investigation [3] Compliance Status - The following companies were found to be compliant: - Guizhou Jingcheng Pharmaceutical Co., Ltd. - Guizhou Junzhitang Pharmaceutical Co., Ltd. - Guizhou Taibang Biological Products Co., Ltd. - Guizhou Ruihe Pharmaceutical Co., Ltd. - Guizhou Deliangfang Pharmaceutical Co., Ltd. - Guizhou Guangzheng Pharmaceutical Co., Ltd. - Zunyi Liao Yuanhetang Pharmaceutical Co., Ltd. - Guizhou Yikang Pharmaceutical Co., Ltd. - Guizhou Weikang Zifan Pharmaceutical Co., Ltd. - Guizhou Shenqi Pharmaceutical Co., Ltd. - Guizhou Yibai Pharmaceutical Co., Ltd. - Guizhou Xianlong Pharmaceutical Co., Ltd. - Xingyi City Jushan Zhuang Rongchang Oxygen Plant - Guiyang Health Materials Factory - Chishui City Qianbei Industrial Co., Ltd. - Guizhou Yibai Women's Great Pharmaceutical Factory Co., Ltd. - Guiyang Jiren Tang Pharmaceutical Co., Ltd. - Zunyi Wangjiang Oxygen Manufacturing Plant - Guizhou Tongjitang Traditional Chinese Medicine Decoction Pieces Co., Ltd. [3]